Showing 1-10 of 23 grants

Title Institution Researcher Program Duration Total Award Amount
A glucose-responsive cannula of insulin delivery Cornell University Bo Wang Improving Lives 01-March-2023 to 28-February-2025 $181.628,32
Enhancing Functional Maturation of Stem Cell-Derived Beta Cells Using Harmine for Improved Diabetes Therapy Icahn School of Medicine at Mount Sinai Peng Wang Cures 01-July-2025 to 30-June-2026 $305.000,00
Project Equity The Sonia Nabeta Foundation Vivian Nabeta Mission 01-May-2024 to 30-April-2026 $245.172,00
Market Analysis of Insulin Products Utilized by Patients With T1D & Pervasiveness of Insulin Caps Milliman Rebecca Smith Transportfolio 01-January-2025 to 01-October-2025 $545.000,00
Market Analysis of Devices Utilized By Patients With T1D & Eligibility For Future T1D Cell and Gene Therapies Milliman Rebecca Smith Cures 01-January-2025 to 31-October-2025 $380.000,00
Cardiotoxic Circulating Extracellular Vesicles: New Drivers of Type 1 Diabetes-induced Cardiomyopathy Icahn School of Medicine at Mount Sinai Susmita Sahoo Improving Lives 01-April-2025 to 31-March-2026 $199.998,24
Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. Icahn School of Medicine at Mount Sinai Romina Bevacqua Cures 01-April-2025 to 31-March-2027 $559.996,54
Role of oxidative post-translational modifications in generating neoepitopes Weill Medical College of Cornell University Laura Santambrogio Cures 01-April-2025 to 31-March-2028 $600.000,00
Exploring the Effects of Beta Cell Regenerative Drugs on Cell Fate Decisions in Human Pancreatic Islets Icahn School of Medicine at Mount Sinai Esra Karakose Cures 01-March-2025 to 28-February-2030 $999.999,00
Engineering hypoimmune cells for Type 1 Diabetes New York Stem Cell Foundation, Inc. Daniel Paull Cures 01-May-2025 to 30-April-2028 $1.498.415,83